chr15-45105795-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001363711.2(DUOX2):​c.2182G>A​(p.Ala728Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00776 in 1,614,188 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A728D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0072 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0078 ( 62 hom. )

Consequence

DUOX2
NM_001363711.2 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0710
Variant links:
Genes affected
DUOX2 (HGNC:13273): (dual oxidase 2) The protein encoded by this gene is a glycoprotein and a member of the NADPH oxidase family. The synthesis of thyroid hormone is catalyzed by a protein complex located at the apical membrane of thyroid follicular cells. This complex contains an iodide transporter, thyroperoxidase, and a peroxide generating system that includes this encoded protein and DUOX1. This protein is known as dual oxidase because it has both a peroxidase homology domain and a gp91phox domain. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038830042).
BP6
Variant 15-45105795-C-T is Benign according to our data. Variant chr15-45105795-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 235495.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-45105795-C-T is described in Lovd as [Likely_benign]. Variant chr15-45105795-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00721 (1098/152344) while in subpopulation AMR AF = 0.0218 (334/15310). AF 95% confidence interval is 0.0199. There are 10 homozygotes in GnomAd4. There are 576 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DUOX2NM_001363711.2 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 34 ENST00000389039.11 NP_001350640.1
DUOX2NM_014080.5 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 34 NP_054799.4 Q9NRD8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DUOX2ENST00000389039.11 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 34 1 NM_001363711.2 ENSP00000373691.7 X6RAN8
DUOX2ENST00000603300.1 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 34 1 ENSP00000475084.1 Q9NRD8
DUOX2ENST00000558383.1 linkn.3913G>A non_coding_transcript_exon_variant Exon 12 of 17 5

Frequencies

GnomAD3 genomes
AF:
0.00718
AC:
1093
AN:
152226
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00106
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0218
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00386
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00889
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.00814
AC:
2046
AN:
251212
AF XY:
0.00764
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.0154
Gnomad ASJ exome
AF:
0.00834
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00268
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.00897
GnomAD4 exome
AF:
0.00782
AC:
11429
AN:
1461844
Hom.:
62
Cov.:
32
AF XY:
0.00778
AC XY:
5659
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00137
AC:
46
AN:
33478
Gnomad4 AMR exome
AF:
0.0159
AC:
713
AN:
44724
Gnomad4 ASJ exome
AF:
0.00708
AC:
185
AN:
26136
Gnomad4 EAS exome
AF:
0.0000252
AC:
1
AN:
39700
Gnomad4 SAS exome
AF:
0.00310
AC:
267
AN:
86258
Gnomad4 FIN exome
AF:
0.00416
AC:
222
AN:
53380
Gnomad4 NFE exome
AF:
0.00847
AC:
9423
AN:
1112004
Gnomad4 Remaining exome
AF:
0.00831
AC:
502
AN:
60396
Heterozygous variant carriers
0
728
1456
2184
2912
3640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00721
AC:
1098
AN:
152344
Hom.:
10
Cov.:
32
AF XY:
0.00773
AC XY:
576
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.00106
AC:
0.0010582
AN:
0.0010582
Gnomad4 AMR
AF:
0.0218
AC:
0.0218158
AN:
0.0218158
Gnomad4 ASJ
AF:
0.00605
AC:
0.00604839
AN:
0.00604839
Gnomad4 EAS
AF:
0.000578
AC:
0.000578035
AN:
0.000578035
Gnomad4 SAS
AF:
0.00414
AC:
0.0041425
AN:
0.0041425
Gnomad4 FIN
AF:
0.00386
AC:
0.00386137
AN:
0.00386137
Gnomad4 NFE
AF:
0.00889
AC:
0.00889366
AN:
0.00889366
Gnomad4 OTH
AF:
0.0128
AC:
0.012772
AN:
0.012772
Heterozygous variant carriers
0
58
116
173
231
289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00871
Hom.:
25
Bravo
AF:
0.00893
TwinsUK
AF:
0.00620
AC:
23
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00791
AC:
68
ExAC
AF:
0.00760
AC:
923
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0115
EpiControl
AF:
0.0116

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 23, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DUOX2: BP4, BS1, BS2 -

Thyroid dyshormonogenesis 6 Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Meckel syndrome, type 11 Benign:1
-
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

The heterozygous p.Ala728Thr variant in DUOX2 has been identified in an individual with congenital hypothyroidism (PMID: 21565790), and has been identified in >1% of Latino chromosomes and 7 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In vitro functional studies provide some evidence that the p.Ala728Thr variant may not impact protein function (PMID: 21565790). However, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely benign for autosomal recessive congenital hypothyroidism. -

DUOX2-related disorder Benign:1
Jul 30, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.16
DANN
Benign
0.90
DEOGEN2
Benign
0.011
T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.23
T;T
MetaRNN
Benign
0.0039
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.97
.;L
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.95
N;.
REVEL
Benign
0.0090
Sift
Benign
0.37
T;.
Sift4G
Benign
0.56
T;T
Polyphen
0.0070
.;B
Vest4
0.038
MVP
0.59
MPC
0.057
ClinPred
0.00028
T
GERP RS
-3.5
Varity_R
0.029
gMVP
0.13
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138353181; hg19: chr15-45397993; API